(Q47993868)

7 February 2018

title

Sero-epidemiology of Bordetella pertussis in England and Wales (English)

1 reference

7 February 2018

1 reference

2

1 reference

7 February 2018

Nick Andrews

4

object named as

Andrews N

1 reference

7 February 2018

Elizabeth Miller

6

object named as

Miller E

1 reference

7 February 2018

author name string

Nardone A

1

1 reference

7 February 2018

Maple PA

3

1 reference

7 February 2018

Gay NJ

5

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

7 February 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

9-10

1 reference

7 February 2018

page(s)

1314-1319

1 reference

7 February 2018

Effect of age on outcome and epidemiology of infectious diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Frequency of unrecognized Bordetella pertussis infections in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Pertussis in adults: frequency of transmission after household exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Deaths from pertussis are underestimated in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Ten years of serological surveillance in England and Wales: methods, results, implications and action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

European Sero-Epidemiology Network: standardisation of the assay results for pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Epidemiology of pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Age and dose interval as factors in agglutinin formation to pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Bordetella pertussis surveillance in England and Wales: 1995-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.08.039

1 reference

7 February 2018

1 reference

7 February 2018